Loading…

Boston Scientific has agreed to acquire SoniVie Ltd., a developer of the TIVUS Intravascular Ultrasound System for renal denervation therapy to treat hypertension. The deal expands Boston Scientific's interventional cardiology portfolio.
“We believe the addition of the differentiated, ultrasound-based TIVUS system can complement our expansive interventional portfolio with a minimally invasive therapy for patients with hypertension.”sonivie.com
Summarized from public sources; check the original articles before acting on it.